Fundraising FoxClarus Lifesciences
Venture capitalCambridge · 5 people tracked
Find your way into Clarus Lifesciences
Fund manager profile
Clarus Lifesciences is a venture fund manager based in Cambridge. SEC filings show 1 venture fund on record, most recently Clarus Lifesciences III, L.P. ($375M offering) filed June 2014.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 5 people
from public directoriesWhat they invest in
from 1 of 1 portfolio companiesBiotech ×1Healthtech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro path
CalciMedica is a clinical-stage biopharmaceutical company developing CRAC (calcium release-activated calcium) channel inhibition therapies for serious acute and chronic inflammatory, immunologic, and cardiopulmonary diseases.
BiotechHealthtechLa Jolla, US
Kenneth A. Stauderman(Co-founder)inGonul Velicelebi(Co-founder)Daniel Geffken(Executive Officer)A. Rachel Leheny(Executive Officer, Director)Michael J. Dunn(Executive Officer)inStephen Bardin(Chief Financial Officer)in
Co-investorsAisling CapitalSanderling VenturesClarus VenturesOrbiMed
Exits · 1
1 IPOsCalciMedica NASDAQ: CALC www.calcimedica.comNASDAQ: CALC
IPO stake values · per SEC filings
Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.
| Company | Owned | IPO price | At IPO | Stake value |
|---|---|---|---|---|
| CalciMedica NASDAQ: CALC www.calcimedica.com | 8.4% | $16.00 | Sep 2020 | $26.9M |
Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).
Frequently asked questions
- Where is Clarus Lifesciences located?
- Clarus Lifesciences is headquartered in Cambridge, US.